Navigation Links
Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
Date:10/13/2010

the first week following a one-time application compared to patients receiving standard of care therapy.  In the first week following treatment, the radius of Excellagen-treated wounds decreased on average by 0.21 cm compared to 0.08 cm for standard of care-treated wounds (N=47, p = 0.018).  The apparent treatment effect was particularly evident in patients with larger-sized wounds (>3.0 cm2). For example, at 12-weeks, 45% of all Excellagen-treated wounds achieved complete closure, compared to 31% in the standard of care group, representing a 45% overall improvement.  For wounds >3 cm2 in area at screening, 33% of Excellagen-treated wounds achieved closure by 12 weeks compared to 0% for standard of care.  In addition, 74% of all Excellagen-treated wounds achieved >/= 90% wound area reduction at 12 weeks compared to 44% in the standard of care group, representing a 68% relative improvement.

Excellagen is pending clearance by the U.S. Food and Drug Administration (FDA) and until such time as the product is cleared for marketing by the FDA, all claims of safety and effectiveness remain subject to review by the FDA.

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations.  Cardium's current investment portfolio includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium lifestyle medicinals brand platform.  The Company's lead product candidates include: (1) Excellagen™ topical gel, for wound care management, which Cardium plans to market launch in the fourth quarter subject to pending FDA 510(k) clearance; and (2) Generx®, a DNA-based angiogenic cardiovascular biologic for patients in international markets wit
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Nuclear medicine ... 2015. Radiopharmaceuticals/ Nuclear are drugs that ... imaging field to diagnose and treat diseases. ... Increasing awareness for radiopharmaceuticals, and ready availability of ... market. Furthermore, increased public awareness and use of ...
(Date:9/23/2014)... 23, 2014 FDNA ... d,une série de démonstrations personnelles   ... domaine de l,analyse de la dysmorphologie assistée ... n° 1035 lors de la réunion ASHG 2014, qui ... , en Californie. FDNA présentera la ...
(Date:9/23/2014)... Dans les secteurs ... ferroviaire ou encore l,énergie, les machines, de ... à leurs données. Ces données de masse ... cœur des voitures, trains, avions, appareils médicaux… ... le nombre de machines connectées d,ici 2020. ...
Breaking Medicine Technology:Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3Altran transforme le big data du monde industriel en nouveau business 2
... ThermalTherapeutic Systems, Inc. (TTS), maker of portable ... F.H. Smith as President and Chief Executive Officer. Mr. ... operational executive in the high-tech sector, focused on biotech, ... F. Vennare will transition to the role of Executive ...
... 2011 Bay Sleep, the West Coast,s largest and ... its newest, state-of-the-art sleep clinic in Oakland, California.  Located ... Sleep,s 16th clinic open for business. Services include sleep ... dispensing CPAP and other therapies for patients diagnosed with ...
Cached Medicine Technology:ThermalTherapeutic Systems, Inc. Names Gardiner F. H. Smith, President and Chief Executive Officer 2Bay Sleep Clinic Continues Growth in California and Beyond 2
(Date:9/23/2014)... 23, 2014 Grinnell Mutual seeks ... projects in the Midwest. Working Together Making It ... non-profit organizations with projects positively impacting their communities. ... marketplace make their communities a better places,” said ... Community Relations Barb Baker. “Their leadership—as coaches, as ...
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... A national report showing the benefits of ... for providing Medicaid services was released today by ... report, "Why Congress Must Save the Medicaid Primary ... to Ensure Access to Life-Saving Primary Care Will ... Medicaid patients, access to internists and pediatricians (and ...
(Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
(Date:9/23/2014)... 2014 SOURCE: Solutions from Our ... were made to Rimidi Diabetes and ... with business solutions to challenges faced by patients and ... collaboration between The Hitachi Foundation, Village ... entrepreneurs with the investment capital, mentoring, and support needed ...
Breaking Medicine News(10 mins):Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... Cardiac Science (Nasdaq: CSCX ), a ... informatics products, today announced today that it will present ... at the Ritz Carlton Laguna Nigel. John Hinson, president ... strategy and recent financial results during the Company,s presentation ...
... & Sullivan to Host Quarterly Analyst Briefing on ... The Chemicals Group at Frost & Sullivan ... Analyst Briefing Presentation on Medical Trends Impacting the ... Thursday, 26 February, 2009 at 3 p.m. GMT.(Logo: ...
... 17 Microscopic insects called dust mites are the leading cause of ... indoor allergens are pet dander and dust mold. Dust mites are ... carpets by the tens of millions. There can be as many ... written by Jay DeFoore titled " Is your ...
... Arkansas-based electronic medical transcription and document management software provider, will ... , ... Little Rock, AR (PRWeb) ... document management software provider eMedDox (formerly Health Data Services, LLC) ...
... getting pharmaceutical companies more directly involved in helping patients in need ... the YourRxCard free prescription drug card. The company also announced new ... , privately funded by Group Net LLC. , ... ...
... doctors, pharmacists and other healthcare professionals a free, unique medical ... For posting occasional prescription drug information and insight on PrescriptionDrug-Info.com, ... inbound links to the URL of their choice. , ... ...
Cached Medicine News:Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 3Health News:Are You Really Sleeping on Clean Bedsheets? 2Health News:New Website Coming Soon for Electronic Medical Transcription Company 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 2Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 3Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 4Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 5Health News:Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009 6Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 2Health News:Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals 3
The Bledsoe Flatform Boot is designed with a flat innersole for procedures where toe dorsiflexion is not permissible....
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Bauerfeind™ AchilloTrain® The viscoelastic insert runs ... application of pressure and targeted intermittent ... reduction of painful irritation of the ... integrated viscoelastic heel wedge (raises heel ...
Medicine Products: